Table 4 Precision, Recall and F-score for individual categories across the top eight genes.
From: Identifying the status of genetic lesions in cancer clinical trial documents using machine learning
| Â | Two-stage classifier | Single-stage classifier | ||||
|---|---|---|---|---|---|---|
Category | Precision | Recall | F-score | Precision | Recall | F-score |
Genetic lesion detected | 75.4% | 92.0% | 82.9% | 78.4% | 89.4% | 83.5% |
Genetic lesion not detected | 90.2% | 78.0% | 83.7% | 89.4% | 78.0% | 83.3% |
Genetic lesion mentioned | 78.5% | 60.9% | 68.6% | 83.5% | 55.1% | 66.4% |
Gene only | 66.7% | 16.0% | 25.8% | 60.0% | 12.0% | 20.0% |
Drug | 91.0% | 90.3% | 90.6% | 82.0% | 95.2% | 88.1% |
Others | 100% | 93.8% | 96.8% | 100% | 94.3% | 97.1% |